Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 4:1
Drug Approvals
6
FDA:5
SFDA:1
Drug Approvals
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 4
1 (100.0%)Bioequivalence Study of Oseltamivir Phosphate and TAMIFLU Under Fed Condition in Healthy Volunteers
Phase 4
Completed
- Conditions
- Bioequivalence
- Interventions
- First Posted Date
- 2020-09-02
- Last Posted Date
- 2023-02-02
- Lead Sponsor
- Austarpharma, LLC
- Target Recruit Count
- 96
- Registration Number
- NCT04536415
- Locations
- 🇺🇸
Austarpharma Llc, Edison, New Jersey, United States
News
No news found